"10.1371_journal.pone.0021224","plos one","2011-06-27T00:00:00Z","Ulla Knorr; Maj Vinberg; Allan Hansen; Marianne Klose; Ulla Feldt-Rasmussen; Linda Hilsted; Jørgen Hasselstrøm; Ulrik Gether; Per Winkel; Christian Gluud; Jørn Wetterslev; Lars Vedel Kessing","Department of Psychiatry Copenhagen, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Medical Endocrinology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Biochemistry, Center for Psychiatric Research, Aarhus University Hospital, Aarhus, Denmark; Center for Pharmacogenomics, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark","Conceived and designed the experiments: UK MV AH MK UFR LH JH UG PW CG JW LK. Performed the experiments: UK LK. Analyzed the data: UK MV MK UFR LH JH UG PW CG JW LK. Wrote the paper: UK MV MK UFR LH JH UG PW CG JW LK.","UK, AH, PW, CG, and JW declare no competing interests. MV has been a speaker for Eli Lilly, Wyeth, Jannsen Cilag, AstraZeneca and Pfizer. MK and UFR have been speakers for Novo Nordisk, Pfizer and Novartis. LVK has been a consultant for Bristol-Myers Squibb, Eli Lilly, H. Lundbeck, AstraZeneca, Pfizer, Wyeth, and Servier. The AGENDA trial has received non-restricted grants from non-profit and for-profit organizations. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","06","Ulla Knorr","UK",12,FALSE,12,2,11,11,TRUE,TRUE,FALSE,0,NA,FALSE
